Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply

Affiliations

Comment

John H Beigel et al. N Engl J Med. 2020.

. 2020 Sep 3;383(10):994.

doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.

¹ National Institute of Allergy and Infectious Diseases, Bethesda, MD jbeigel@niaid.nih.gov.

No abstract available

Comment on

Remdesivir for the Treatment of Covid-19 - Preliminary Report.
Gillenwater S, Rahaghi F, Hadeh A. Gillenwater S, et al. N Engl J Med. 2020 Sep 3;383(10):992. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10. N Engl J Med. 2020. PMID: 32649074 No abstract available.
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
McMahon JH, Udy A, Peleg AY. McMahon JH, et al. N Engl J Med. 2020 Sep 3;383(10):992-993. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10. N Engl J Med. 2020. PMID: 32649075 No abstract available.
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
McCaw ZR, Kim DH, Wei LJ. McCaw ZR, et al. N Engl J Med. 2020 Sep 3;383(10):993. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10. N Engl J Med. 2020. PMID: 32649076 No abstract available.
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
Olalla J. Olalla J. N Engl J Med. 2020 Sep 3;383(10):993-994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10. N Engl J Med. 2020. PMID: 32649077 No abstract available.